- Dihydroproscar
-
-
2026-10-12
- CAS:98319-24-5
- Min. Order: 1G
- Purity: ≥98% HPLC
- Supply Ability: 1000KG
- Dihydroproscar
-
-
2026-10-09
- CAS:98319-24-5
- Min. Order: 1g
- Purity: 97%-102% HPLC
- Supply Ability: 200kg
- Dihydroproscar
-
-
2026-08-25
- CAS:98319-24-5
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 1000kg
|
| | Dihydroproscar Basic information |
| Product Name: | Dihydroproscar | | Synonyms: | 3-Oxo-4-aza-5A-androstane-17beta-(N-T-butylcarboxamide);N-TERT-BUTYL-3-OXO-4-AZA-5ALPHA-ANDROST-17BETA-CARBOXAMIDE;F9 / FINASTERIDE INTERMEDIATE;Dihydro Finasteride;(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-DiMethylethyl)hexadecahydro-4a,6a-diMethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxaMide;(5α,17β)-N-(1,1-DiMethylethyl)-3-oxo-4-azaandrostane-17-carboxaMide;[4aR-(4aα,4bβ,6aα,7α,9aβ,9bα,11aβ)]-N-(1,1-DiMethylethyl)hexadecahydro-4a,6a-diMethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxaMide;1,2-Dihydrofinasteride | | CAS: | 98319-24-5 | | MF: | C23H38N2O2 | | MW: | 374.56 | | EINECS: | 251-228-4 | | Product Categories: | Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;INTERMEDIATESOFFINASTERIDE | | Mol File: | 98319-24-5.mol |  |
| | Dihydroproscar Chemical Properties |
| Melting point | 273-275 °C | | Boiling point | 569.4±49.0 °C(Predicted) | | density | 1.051±0.06 g/cm3(Predicted) | | storage temp. | −20°C | | solubility | Chloroform (Slightly), Methanol | | pka | 15.94±0.70(Predicted) | | form | powder | | color | yellow | | Optical Rotation | 55.5°(C=0.01g/ml MEOH) | | InChIKey | ZOIUUCNFVDJSJK-WSBQPABSSA-N | | SMILES | N1[C@@]2([H])[C@@](C)([C@@]3([H])CC[C@@]4(C)[C@]([H])([C@]3([H])CC2)CC[C@@H]4C(NC(C)(C)C)=O)CCC1=O |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26-36 | | WGK Germany | 3 | | HS Code | 29242990 |
| | Dihydroproscar Usage And Synthesis |
| Chemical Properties | White Solid | | Uses | The reduced product of Finasteride (F342000): a mechanism-based inhibitor of human prostate and skin steroid 5α-reductase. It forms an enzyme-bound NADP-dihydrofinasteride adduct during this inhibitor
y process. | | Uses | Dihydro Finasteride (Finasteride EP Impurity A) is the reduced product of Finasteride (F342000): a mechanism-based inhibitor of human prostate and skin steroid 5α-reductase. It forms an enzyme-bound NADP-dihydrofinasteride adduct during this inhibitory process. |
| | Dihydroproscar Preparation Products And Raw materials |
|